您的当前位置:首页 > 行业数据 > RBD4059的I期临床中,FXI抗原(左)和FXI活性(右)相较于基线的变化值
图片属性
图片格式:PNG 图片大小:577KB 图片尺寸:2302*781
同报告图片
 / 4
RBD4059的I期临床中,FXI抗原(左)和FXI活性(右)相较于基线的变化值_第1页
IyMjIEZYSSDmipfljp/nm7jlr7nln7rnur/lj5jljJblgLzvvIgl77yJCnwg56CU56m25pelIHwg5a6J5oWw5YmCIHwgNTBtZyB8IDE1MG1nIHwgNDAwbWcgfCA2MDBtZyB8CnwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18CnwgMSAgICAgIHwgMTAwICAgIHwgMTAwICB8IDEwMCAgIHwgMTAwICAgfCAxMDAgICB8CnwgOCAgICAgIHwgMTAyICAgIHwgNzIgICB8IDYwICAgIHwgNDUgICAgfCAzNSAgICB8CnwgMTUgICAgIHwgMTAxICAgIHwgNjUgICB8IDQ1ICAgIHwgMzIgICAgfCAyMiAgICB8CnwgMjIgICAgIHwgMTAwICAgIHwgNTggICB8IDM2ICAgIHwgMjUgICAgfCAxNyAgICB8CnwgMjkgICAgIHwgOTkgICAgIHwgNDggICB8IDI4ICAgIHwgMjAgICAgfCAxMyAgICB8CnwgNDMgICAgIHwgOTggICAgIHwgNDIgICB8IDI0ICAgIHwgMTcgICAgfCAxMSAgICB8CnwgNTcgICAgIHwgOTcgICAgIHwgMzkgICB8IDIxICAgIHwgMTYgICAgfCAxMCAgICB8CnwgNzEgICAgIHwgOTYgICAgIHwgMzggICB8IDIwICAgIHwgMTUgICAgfCA5ICAgICB8CnwgODUgICAgIHwgOTUgICAgIHwgMzcgICB8IDE5ICAgIHwgMTQgICAgfCA5ICAgICB8CnwgMTEzICAgIHwgOTQgICAgIHwgNDEgICB8IDIzICAgIHwgMTYgICAgfCAxMiAgICB8CnwgMTQxICAgIHwgOTcgICAgIHwgNDkgICB8IDI3ICAgIHwgMTkgICAgfCAxNSAgICB8CnwgMTY5ICAgIHwgOTUgICAgIHwgNTUgICB8IDMwICAgIHwgMjMgICAgfCAyMyAgICB8CgoKIyMjIEZYSSDmtLvmgKfnm7jlr7nln7rnur/lj5jljJblgLzvvIgl77yJCnwg56CU56m25pelIHwg5a6J5oWw5YmCIHwgNTBtZyB8IDE1MG1nIHwgNDAwbWcgfCA2MDBtZyB8CnwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18CnwgMSAgICAgIHwgMTAwICAgIHwgMTAwICB8IDEwMCAgIHwgMTAwICAgfCAxMDAgICB8CnwgOCAgICAgIHwgMTA4ICAgIHwgNzAgICB8IDYwICAgIHwgNTAgICAgfCA0MCAgICB8CnwgMTUgICAgIHwgMTA1ICAgIHwgNTggICB8IDQ1ICAgIHwgMzggICAgfCAyOCAgICB8CnwgMjIgICAgIHwgMTAzICAgIHwgNDcgICB8IDM1ICAgIHwgMzAgICAgfCAyMiAgICB8CnwgMjkgICAgIHwgMTAyICAgIHwgMzggICB8IDI4ICAgIHwgMjQgICAgfCAxNyAgICB8CnwgNDMgICAgIHwgMTAxICAgIHwgMzQgICB8IDIzICAgIHwgMjAgICAgfCAxNCAgICB8CnwgNTcgICAgIHwgMTAwICAgIHwgMzMgICB8IDIxICAgIHwgMTggICAgfCAxMiAgICB8CnwgNzEgICAgIHwgMTAxICAgIHwgMzQgICB8IDIxICAgIHwgMTcgICAgfCAxMSAgICB8CnwgODUgICAgIHwgMTAyICAgIHwgMzUgICB8IDIyICAgIHwgMTcgICAgfCAxMSAgICB8CnwgMTEzICAgIHwgMTA0ICAgIHwgMzkgICB8IDI1ICAgIHwgMTkgICAgfCAxMyAgICB8CnwgMTQxICAgIHwgMTA2ICAgIHwgNDYgICB8IDMxICAgIHwgMjIgICAgfCAxNSAgICB8CnwgMTY5ICAgIHwgMTA3ICAgIHwgNTQgICB8IDQwICAgIHwgMjYgICAgfCAxOCAgICB8CgoK6LWE5paZ5p2l5rqQ77ya55Ge5Y2a55Sf54mp5oub6IKh5Lmm
RBD4059的I期临床中,FXI抗原(左)和FXI活性(右)相较于基线的变化值_第2页
RBD4059的I期临床中,FXI抗原(左)和FXI活性(右)相较于基线的变化值_第3页
RBD4059的I期临床中,FXI抗原(左)和FXI活性(右)相较于基线的变化值_第4页
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
RBD4059的I期临床中,FXI抗原(左)和FXI活性(右)相较于基线的变化值_第5页
所属报告: FXI、FXIa抑制剂行业研究报告:从靶点到管线FXI引领抗凝产业新变革-260225(21页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠